Characterization of a 7,8-benzoflavone double effect on CFTR Cl- channel activity

Journal of Membrane Biology

Volumn 220, Issue 1-3, 2007, Pages 1-9

  Ferrera, Loretta ^a   Pincin, Chiara ^a   Moran, Oscar ^a  

^a CNR   (Italy)

Author keywords

7,8 Benzoflavone; Cl channel; Cystic fibrosis transmembrane conductance regulator

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA NAPHTHOFLAVONE; CHLORIDE CHANNEL; FLAVONE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIMERIZATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PATCH CLAMP; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOFLAVONES; CHLORIDE CHANNELS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ION CHANNEL GATING; KINETICS; MEMBRANE POTENTIALS; MICE; NIH 3T3 CELLS; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; PROTEIN BINDING;

EID: 37249015548     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-007-9066-4     Document Type: Article

References (33)

1. Ai T, Bompadre SG, Wang X, Hu S, Li M, Hwang TC (2004) Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents. Mol Pharmacol 65:1415-1426
2. Al-Nakkash L, Hu S, Li M, Hwang TC (2001) A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs. J Pharmacol Exp Ther 296:464-472
3. - current by phloxine B. Br J Pharmacol 131:433-440
4. Becq F, Mettey Y, Gray MA, Galietta LJ, Dormer LR, Merten M, Metaye T, Chappe V, Marvingt-Mounir C, Zegarra-Moran O, Tarran R, Bulteau L, Derand R, Pereira MM, McPherson MA, Rogier C, Joffre M, Argent BE, Sarrohuilhe D, Kammouni W, Figarella C, Verrier B, Gola M, Vierfond JM (1999) Development of substituted benzo[c]quiniolizinium compounds as novel activators of the cystic fibrosis chloride channel. J Biol Chem 274:27415-27425
5. Caci E, Folli C, Zegarra-Moran O, Ma T, Springsteel MF, Sammelson RE, Nantz MH, Kurth MJ, Verkman AS, Galietta LJ (2003) CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds. Am J Physiol 285:L180-L188
6. Cai Z, Sheppard DN (2002) Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity. J Biol Chem 277:19546-19553
7. - channels via a tyrosine kinase- and protein phosphatase-independent mechanism. Am J Physiol 273:C747-C753
8. Galietta L, Springsteel M, Eda M, Niedzinski E, By K, Haddadin M, Kurth M, Nantz M, Verkman A (2001) Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds. J Biol Chem 276:19723-19728
9. Guay-Broder C, Jacobson KA, Barnoy S, Cabantchik ZI, Guggino WB, Zeitlin PL, Turner RJ, Vergara L, Eidelman O, Pollard HB (1995) A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Biochemistry 34:9079-9087
10. Hamill O, Marty A, Neher E, Sakmann B, Sigworth F (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pfluegers Arch 391:85-100
11. Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ (1996) Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 270:C1544-C1555
12. -. Am J Physiol 275:G1221-G1226
13. Illek B, Lizarzaburu M, Lee V, Nantz M, Kurth M, Fischer H (2000) Structural determinants for the activation and block of CFTR-mediated chloride currents by apigenin. Am J Physiol 279:C1838-C1846
14. - channels expressed in mammalian cells. J Physiol 508(Pt 2):379-392
15. - channels expressed in murine cell line. J Physiol 524:317-330
16. Mense M, Vergani P, White DM, Altberg G, Nairn AC, Gadsby DC (2006) In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J 25:4728-4739
17. Moran O, Galietta L, Zegarra-Moran O (2005) Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains. Cell Mol Life Sci 62:446-460
18. Moran O, Zegarra-Moran O (2005) A quantitative description of the activation and inhibition of CFTR by potentiators: genistein. FEBS Lett 579:3979-3983
19. Randak C, Auerswald EA, Assfalg-Machleidt I, Reenstra WW, Machleidt W (1999) Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein. J Biochem 340:227-235
20. Riordan JR, Rommens JM, Kerem B, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073
21. Schultz BD, Singh AK, Devor DC, Bridges RJ (1999) Pharmacology of CFTR chloride channel activity. Physiol Rev 79:S109-S144
22. Smit LS, Wilkinson DJ, Mansoura MK, Collins FS, Dawson DC (1993) Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA 90:9963-9967
23. Sullivan LP, Wallace DP, Grantham JJ (1998) Epithelial transport in polycystic kidney disease. Physiol Rev 78:1165-1191
24. Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, Galietta LJ (2004) Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 558:52-56
25. Tsui LC, Durie P (1997) Genotype and phenotype in cystic fibrosis. Hosp Pract (Minneapolis) 32:15-18, 123-129, 134, passim
26. Vais H, Zhang R, Reenstra WW (2004) Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activation. Am J Physiol 287:C737-C745
27. Vergani P, Lockless SW, Nairn AC, Gadsby DC (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433:876-880
28. - channels. J Gen Physiol 121:17-36
29. Wang F, Zeltwanger S, Yang I, Nairn A, Hwang T (1998) Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects. J Gen Physiol 111:477-490
30. Weinreich F, Wood P, Riordan J, Nagel G (1997) Direct action of genistein on CFTR. Pfluegers Arch 434:484-491
31. Welsh MJ, Smith AE (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-1254
32. Zegarra-Moran O, Romio L, Folli C, Caci E, Becq F, Vierfond JM, Mettey Y, Cabrini G, Fanen P, Galietta LJ (2002) Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07. Br J Pharmacol 137:504-512
33. Zegarra-Moran O, Monteverde M, Galietta LJV, Moran O (2007) Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulatot potentiators. Interaction between activation and inhibition. J Biol Chem 282:9098-9104